Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

NCT02315638 · clinicaltrials.gov ↗
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Long term safety follow-up no longer required

Conditions

Sponsor

Tacere Therapeutics, Inc.